044960 — Eagle Veterinary Technology Co Balance Sheet
0.000.00%
- KR₩45bn
- KR₩40bn
- KR₩43bn
Annual balance sheet for Eagle Veterinary Technology Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8,826 | 5,389 | 6,092 | 7,200 | 10,424 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,367 | 8,380 | 8,908 | 9,586 | 9,341 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26,716 | 26,242 | 26,350 | 28,070 | 30,802 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19,062 | 19,482 | 23,867 | 24,518 | 24,803 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 52,601 | 54,866 | 58,479 | 61,237 | 63,982 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,328 | 8,207 | 9,845 | 10,073 | 8,595 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11,771 | 11,912 | 13,136 | 12,647 | 12,070 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 40,830 | 42,954 | 45,343 | 48,590 | 51,912 |
| Total Liabilities & Shareholders' Equity | 52,601 | 54,866 | 58,479 | 61,237 | 63,982 |
| Total Common Shares Outstanding |